Taiko Pharmaceutical Co., Ltd. (4574)
Market Closed
12 Aug, 06:00
JPX JPX Primary ¥
255. 00
+3
+1.1905%
¥
15.16B Market Cap
- P/E Ratio
- Div Yield
119,900 Volume
- Eps
¥ 252
Previous Close Want to track 4574 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taiko Pharmaceutical Co., Ltd. (4574) Statistics
Valuation metrics
Market Cap 15.16B
Enterprise value 9.76B
Trailing P/E (ttm) 23.55
Forward P/E 55.43
PEG ratio -0.92
Price/Sales (ttm) 2.05
Price/Book (mrq) 1.53
Enterprise Value/Revenue 1.58
Enterprise Value/EBITDA 12.66
Overview
Shares outstanding 50.25M
Float 23.83M
Shares short -
% Held by insiders 0.37%
% Held by institutions 0.06%
Average volume (10 days) 133.99K
Average volume (90 days) 103.8K
Price summary
52-Week low 246
52-Week high 335
Beta 0.05
50-Day moving average 265.51
200-Day moving average 280.63
Dividends and splits
Forward annual dividend rate 13.2
Forward annual dividend yield 0.0514%
Trailing annual dividend rate 3.3
Trailing annual dividend yield 0.0131%
5-Year annual dividend yield 1.04%
Payout ratio 0.18
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 30 Mar 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin 0.09%
Operating margin 0.05%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.07%
Income Statement
Revenue (ttm) 22.46B
Revenue per share (ttm) 122.64
Quarterly revenue growth (yoy) 0.16%
Gross profit (ttm) 15.54B
EBITDA 881M
Net income to common (ttm) 4.18B
Diluted EPS (ttm) 10.67
Quarterly earnings growth (yoy) -0.33%
Balance Sheet
Total cash (mrq) 4.94B
Total cash per share (mrq) 76.26
Total debt (mrq) 94M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 4.14%
Book value per share (mrq) 164.53
Cash Flow
Cash flow statement 1.03B
Levered free cash flow (LFCF) 923M
